Table 1.
Trypanosomatid | Disease | Vector | People at risk (millions) | Prevalence (millions) | Available chemotherapy |
---|---|---|---|---|---|
Leishmania spp. | cutaneous, mucocutaneous or visceral leishmaniasis | phlebotomine sand fly | 350 | 12 | amphotericin B, miltefosine, paromomycin, sodium stibogluconate, meglumine antimoniate |
Trypanosoma cruzi | Chagas’ disease | triatomine | 100 | 10 | nifurtimox, benznidazole |
Trypanosoma brucei | human sleeping sickness | tsetse fly | 70 | 0,03* | pentamidine, suramine, melarsoprol, eflornithine, nifurtimox |
Although 30,000 cases are reported annually, WHO estimates that about 300,000 infected individuals remain ignored in the field, due to difficulties in diagnosis and remoteness of affected areas.